Strong global surveillance from the WHO and CDC shows no novel pathogen has achieved sustained human-to-human transmission at scale in 2026, underpinning the 89.5% market-implied odds against a new pandemic. Recent developments include a localized hantavirus cluster on the MV Hondius cruise ship in early May, involving respiratory cases and deaths from the Andes strain, yet limited droplet spread and known epidemiology have kept WHO risk assessments low. Ongoing mpox clade IIb transmission and sporadic H5N1 avian influenza infections remain contained without exponential growth or public health emergency declarations. With half the year elapsed and no shifts in model consensus or confirmed trajectories for threats like influenza D or Marburg, trader consensus reflects the absence of conditions needed for pandemic emergence.